European Sovereignty Monitor
Sign up free

Industry, investment and R&D

Isomorphic Labs raises USD 5 billion Series C for AI drug design

Isomorphic Labs, the Alphabet-backed, London-based AI drug design firm, raised USD 5 billion in a Series C round. Greenoaks and Sequoia Capital co-led it, joined by Andreessen Horowitz, Alphabet and the UK Sovereign AI Fund.

Verified AI-drafted Isomorphic Labs press release, 17 November 2026

What the source does not establish. Does not establish the company's valuation or the split of ownership between Alphabet and the outside investors.

Index score. No movement: no answer to who owns, who operates, whose law governs or who made the parts changes. Weight 0. USD5bn round closed but ownership split between Alphabet and others undisclosed. European Sovereignty Index

How this item was made. Drafted by an AI system (Claude (Anthropic)) from the source cited above and published under the editor’s responsibility without a person reading it first. How the record is made

What the tags mean: VerifiedReportedAI-draftedAI-drafted, editor-readHuman-writtenWhat the tags mean

Previously in Industry, investment and R&D

ReportedAI-drafted EU's EIC backs Paris satellite-to-phone start-up Univity with up to EUR 12.5 million VerifiedAI-drafted Wallenberg Investments takes minority stake in Swedish simulation firm Algoryx ReportedAI-drafted Dutch startup Elysian Aircraft raises over EUR 12 million for dual-use aircraft tech

All Industry, investment and R&D news →